Physician

Aixa Curbelo-Irizarry, M.D.

According to 2025 Medicare claims, Aixa Curbelo-Irizarry, M.D. (NPI: 1447264353) practices infectious disease in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is ORLANDO HEALTH MEDICAL GROUP INC (NPI: 1669429577; TIN: 593259553) and primary practice location at 34711-1979.

Curbelo-Irizarry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 509 traditional Medicare patients, billed 1,194 HCPCS/CPT codes, and received $101,089 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,090 prescription claims across 185 beneficiaries totaling $1,753,124 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2022 DME data shows 24 claims. Open Payments data shows 5 records totaling $98. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $616,382 to $1,753,124. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	515	2,026	$135,637
2016	409	1,202	$77,714
2017	428	1,176	$79,809
2018	485	1,448	$105,528
2019	552	1,804	$139,499
2020	575	1,656	$135,848
2021	526	1,380	$119,061
2022	511	1,306	$106,586
2023	490	1,280	$110,797
2024	509	1,194	$101,089

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	158	789	$616,382
2016	87	464	$419,920
2017	75	438	$347,894
2018	129	660	$548,226
2019	135	745	$746,904
2020	108	595	$795,033
2021	132	817	$1,070,345
2022	154	937	$1,505,752
2023	163	1,007	$1,544,867
2024	185	1,090	$1,753,124

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	39	$44,764
2021	N/R	36	$43,946
2022	N/R	24	$4,577
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	131	138	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	62	92	$97
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	182	191	$94
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	150	268	$92
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	245	397	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	94	2,820	$395,136
Nuzyra	Omadacycline Tosylate	11	330	$176,305
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	40	1,200	$152,520
Tivicay	Dolutegravir Sodium	47	1,410	$134,152
Prezcobix	Darunavir/Cobicistat	38	1,140	$93,945

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$98	ViiV Healthcare Company
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aixa Curbelo-Irizarry, M.D.?

Tedicare shows public-source Medicare data for Aixa Curbelo-Irizarry, M.D. (NPI 1447264353), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aixa Curbelo-Irizarry, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aixa Curbelo-Irizarry, M.D.?

Aixa Curbelo-Irizarry, M.D. is linked to ORLANDO HEALTH MEDICAL GROUP INC (billing NPI 1669429577) in the available physician profile data.

Does Aixa Curbelo-Irizarry, M.D. have Open Payments data?

Aixa Curbelo-Irizarry, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.